TTI expands its service offering at the FDA by being on the winning team on the $75M FDA CSTAR contract:

The Base plus 4 option period engagement would provide full life-cycle management support of the Center for Devices and Radiological Health (CDRH) Submission Tracking And Reporting (CSTAR) system including, development, modernization, and enhancement work (DME) activities to enhance, improve, or otherwise augment the CSTAR suite of applications. The CSTAR contract will also provide business intelligence and data warehousing solution so that it enables advanced analysis of medical device data, presents scorecards and dashboards to monitor organizational performance, and helps FDA meet its Congressional reporting requirements